The discovery of immune cell activity linked to fibrosis could pave the way for treatments beyond inflammation control.

In replacing Hologic, the index committee at S&P Dow Jones opted for a convenience-store retailer instead of another healthcare company Casey's General Stores is getting bumped up from the S&P MidCap ...

Research suggests scientists have identified what drives the development of scar tissue in the intestines of people with ...

Cancer Council NSW is thrilled to announce the allocation of over $6 million in funding for groundbreaking cancer research performed by some of the ...

Edinburgh scientists launch £1.5m Cancer Research UK study to boost immunotherapy for bowel cancer by exposing hidden cells ...

National Geographic Explorer Sammy Ramsey is a self-proclaimed “bundle of quirks and oddities.” Standing tall in his ...

Nobel laureate Sir Michael Houghton and colleagues at Applied Pharmaceutical Innovation (API) outline how rigorous early ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

In this interview, Daszak responds to the inaugural “Scientific Freedom” lecture held at the National Institutes of Health ...

A biotechnology company worth over 10 billion dollars has announced that it is making a determined effort to recreate the ...

A new Edinburgh-based Cancer Research UK-funded study hopes to find a way to ‘sabotage’ bowel cancer cells.

Integrating proteomics with systems biology reveals complex cellular networks, improving disease mechanisms understanding and precision medicine applications.